Fund Holdings — Versant Venture Management, LLC

Total Portfolio Value:
$109.10M
Total Bought:
$8.86M
Total Sold:
$1.39M
Net Transaction:
+$7.47M
Notable People:
Brian G. Atwood, Samuel D. Colella, Bradley J. Bolzon, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, Kirk G. Nielsen, Robin L. Praeger, Charles M. Warden, Brian G. Atwood, Bradley J. Bolzon, Samuel D. Colella, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, Charles M. Warden, Brian G. Atwood, Bradley J. Bolzon, Samuel D. Colella, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, Robin L. Praeger, Charles M. Warden, Brian G. Atwood, Bradley J. Bolzon, Samuel D. Colella, Ross A. Jaffe, William J. Link, Kirk G. Nielsen, Robin L. Praeger, Charles M. Warden, Robin L. Praeger, Robin L. Praeger, Thomas F. Woiwode, Samuel D. Colella, William J. Link, Kirk G. Nielsen, Bradley J. Bolzon, Thomas F. Woiwode, Thomas F. Woiwode, Bradley J. Bolzon, Robin L. Praeger, Kirk G. Nielsen, Thomas F. Woiwode, Versant Ventures Vi Gp-, Versant Venture, Versant Ventures Vii Gp-, Versant Vantage I Gp-Gp,, Bradley J. Bolzon, Jerel Clayton Davis, Robin L. Praeger, Thomas F. Woiwode, Clare Ozawa, Clare Ozawa, Thomas F. Woiwode, Robin L. Praeger, Jerel Clayton Davis, Bradley J. Bolzon, Versant Ventures Vi Gp,, Jerel Clayton Davis, Jerel Clayton Davis, Clare Ozawa, Jerel Clayton Davis, Clare Ozawa, Alexander Volker Mayweg, Alexander Volker Mayweg, Versant Vantage Ii Gp-Gp,, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Robin L. Praeger, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Ventures Viii Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Robin L. Praeger, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Ventures Viii Gp-, Versant Voyageurs Ii Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Robin L. Praeger, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Voyageurs Ii Gp-, Versant Vantage Iii Gp-Gp,, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Ventures Ix Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Voyageurs Iii Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Vantage Iii Gp-Gp,, Versant Ventures Ix Gp-, Versant Voyageurs Iii Gp-, Carlo Dante Rizzuto, Carlo Dante Rizzuto, Carlo Dante Rizzuto, Carlo Dante Rizzuto
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Monte Rosa Therapeutics, Inc.(GLUE)3,180,7803,180,7800$76.97M$37.95M34.78%-$39.03M
Century Therapeutics, Inc.(IPSC)12,166,10912,166,1090$29.81M$20.80M19.07%-$9.00M
Contineum Therapeutics, Inc.(CTNM)542,6281,292,628+750,000$8.89M$17.35M15.90%+$8.45M
Jade Biosciences, Inc.991,783991,7830$22.04M$13.93M12.77%-$8.10M
LENZ Therapeutics, Inc.(LENZ)2,656,8882,656,8880$15.09M$10.20M9.35%-$4.89M
CRISPR Therapeutics AG(CRSP)148,831148,8310$8.12M$8.23M7.55%+$116.1K
Skye Bioscience, Inc.0250,962+250,962$0$404.0K0.37%+$404.0K
Tempest Therapeutics, Inc.(TPST)269,772269,7720$299.4K$225.1K0.21%-$74.4K
Skye Bioscience, Inc.(SKYE)2,007,7040-2,007,704$1.39M$0—-$1.39M
Page 1 of 1
Versant Venture Management, LLC — 13F Holdings — Q3 2026 | TickerTrail